Literature DB >> 25473754

Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.

Mary C Tolcher1, Elizabeth M Swisher, Fabiola Medeiros, Joema F Lima, Jodi L Hilderbrand, Janis L Donovan, Rochelle L Garcia, William A Cliby, Sean C Dowdy.   

Abstract

To determine if selected cases of uterine serous carcinoma (USC) arise from tubal rather than endometrial epithelium. Bilateral fallopian tubes from 38 women with pure USC were entirely submitted for histopathologic examination using the protocol Sectioning and Extensively Examining the FIMbria (SEE-FIM). Non-neoplastic endometrium was extensively sampled. Immunohistochemistry for p53 was performed on all paraffin blocks of fallopian tube and non-neoplastic endometrium. Endometrial intraepithelial carcinoma (EIC) was present in 22 cases (58%). Endometrial p53 foci were identified in 3 patients. There were 11 cases (29%) with fallopian tube involvement; 9 of 11 had tubal wall invasion or lymphatic involvement without serous tubal intraepithelial carcinoma (STIC) and were, therefore, classified as metastatic from the endometrium. STIC was identified in 3 patients (8%). There were 3 cases with tubal p53 foci in non-neoplastic epithelium. EIC was present in 58% of patients, further supporting EIC as a precursor lesion to USC. STIC was present in 8%, suggesting that the fallopian tube may in fact represent the primary lesion in a minority of patients with USC. This finding may account for the early multifocal disease distribution observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25473754      PMCID: PMC4405903          DOI: 10.1097/PGP.0000000000000109

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  40 in total

1.  Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.

Authors:  M E Sherman; P Bitterman; N B Rosenshein; G Delgado; R J Kurman
Journal:  Am J Surg Pathol       Date:  1992-06       Impact factor: 6.394

2.  BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.

Authors:  Kathryn P Pennington; Tom Walsh; Ming Lee; Christopher Pennil; Akiva P Novetsky; Kathy J Agnew; Anne Thornton; Rochelle Garcia; David Mutch; Mary-Claire King; Paul Goodfellow; Elizabeth M Swisher
Journal:  Cancer       Date:  2012-07-18       Impact factor: 6.860

3.  p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.

Authors:  Karoline Leonhardt; Jens Einenkel; Sindy Sohr; Kurt Engeland; Lars-Christian Horn
Journal:  Int J Gynecol Pathol       Date:  2011-09       Impact factor: 2.762

4.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Authors:  Timothy R Rebbeck; Henry T Lynch; Susan L Neuhausen; Steven A Narod; Laura Van't Veer; Judy E Garber; Gareth Evans; Claudine Isaacs; Mary B Daly; Ellen Matloff; Olufunmilayo I Olopade; Barbara L Weber
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

5.  TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.

Authors:  Elisabetta Kuhn; Robert J Kurman; Russell Vang; Ann Smith Sehdev; Guangming Han; Robert Soslow; Tian-Li Wang; Ie-Ming Shih
Journal:  J Pathol       Date:  2011-12-23       Impact factor: 7.996

6.  Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.

Authors:  R A Ambros; M E Sherman; C M Zahn; P Bitterman; R J Kurman
Journal:  Hum Pathol       Date:  1995-11       Impact factor: 3.466

7.  p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.

Authors:  M E Sherman; M E Bur; R J Kurman
Journal:  Hum Pathol       Date:  1995-11       Impact factor: 3.466

Review 8.  Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Authors:  Brian M Slomovitz; Thomas W Burke; Patricia J Eifel; Lois M Ramondetta; Elvio G Silva; Anuja Jhingran; Jonathan C Oh; E Neely Atkinson; Russell R Broaddus; David M Gershenson; Karen H Lu
Journal:  Gynecol Oncol       Date:  2003-12       Impact factor: 5.482

9.  Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.

Authors:  Xi Zhang; Sharon X Liang; Lin Jia; Ning Chen; Oluwole Fadare; Peter E Schwartz; Beihua Kong; Wenxin Zheng
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

10.  FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival.

Authors:  S Memarzadeh; C H Holschneider; R E Bristow; N L Jones; Y S Fu; B Y Karlan; J S Berek; R Farias-Eisner
Journal:  Int J Gynecol Cancer       Date:  2002 Sep-Oct       Impact factor: 3.437

View more
  8 in total

Review 1.  Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.

Authors:  Murray Joseph Casey; Agnes B Colanta
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

Review 2.  Endometrial Cancer and BRCA Mutations: A Systematic Review.

Authors:  Maria Luisa Gasparri; Serena Bellaminutti; Ammad Ahmad Farooqi; Ilaria Cuccu; Violante Di Donato; Andrea Papadia
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

Review 3.  Cell Origins of High-Grade Serous Ovarian Cancer.

Authors:  Jaeyeon Kim; Eun Young Park; Olga Kim; Jeanne M Schilder; Donna M Coffey; Chi-Heum Cho; Robert C Bast
Journal:  Cancers (Basel)       Date:  2018-11-12       Impact factor: 6.639

4.  Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?

Authors:  Amnon Amit; Edmond Sabo; Avielle Movsas; Yamit Efrat-Tamam; Ari Reiss; Emad Matanes; Geula Klorin
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

5.  Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential.

Authors:  Mitchell Acland; Georgia Arentz; Max Mussared; Fergus Whitehead; Peter Hoffmann; Manuela Klingler-Hoffmann; Martin K Oehler
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

Review 6.  The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review.

Authors:  Sameera Rashid; Maria A Arafah; Mohammed Akhtar
Journal:  Adv Anat Pathol       Date:  2022-05-01       Impact factor: 3.875

7.  A Protocol for the Acquisition of Comprehensive Proteomics Data from Single Cases Using Formalin-Fixed Paraffin Embedded Sections.

Authors:  Mitchell Acland; Parul Mittal; Georgia Arentz; Fergus Whitehead; Peter Hoffmann; Manuela Klingler-Hoffmann; Martin K Oehler
Journal:  Methods Protoc       Date:  2022-07-10

8.  Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome.

Authors:  Sheng-Yun Cai; Tian Yang; Yu Chen; Jing-Wen Wang; Li Li; Ming-Juan Xu
Journal:  J Ovarian Res       Date:  2015-07-31       Impact factor: 4.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.